المؤلفون: Alwhaibi, Abdulrahman, Alenazi, Miteb A., Alghadeer, Sultan, Mansy, Wael, Alsaif, Reem A., Abualreesh, Nawaf E., Alanazi, Rakan J., Alroumi, Abdullah, Alanazi, Saleh A.

المصدر: Journal of Clinical Medicine; Jan2025, Vol. 14 Issue 2, p388, 20p

مصطلحات موضوعية: IMMUNE checkpoint inhibitors, ACUTE kidney failure, CANCER treatment, NIVOLUMAB, CANCER patients